Passage Bio Inc (PASG) — Financial Flexibility Index
Passage Bio Inc (PASG) has a Financial Flexibility Index of -0.11x as of September 2025. Free cash flow of $-4.85 Million (operating CF $-4.85 Million minus capex $0.00) represents 0% of total liabilities ($43.04 Million). Also explore Passage Bio Inc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Passage Bio Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Passage Bio Inc across 7 annual periods. Check how strategically is Passage Bio Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Passage Bio Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Passage Bio Inc. For the full company profile including market capitalisation, see PASG stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.16x | $-47.92 Million | $-47.96 Million | $41.15 Million | ▲ +41.5% |
| 2023 | -1.99x | $-78.12 Million | $-78.26 Million | $39.26 Million | ▲ +25.7% |
| 2022 | -2.68x | $-112.94 Million | $-118.21 Million | $42.18 Million | ▲ +3.7% |
| 2021 | -2.78x | $-101.24 Million | $-126.88 Million | $36.42 Million | ▲ +17.9% |
| 2020 | -3.39x | $-78.87 Million | $-80.52 Million | $23.29 Million | ▲ +62.2% |
| 2019 | -8.97x | $-38.20 Million | $-39.90 Million | $4.26 Million | ▼ -2453.3% |
| 2018 | -0.35x | $-16.02 Million | $-18.57 Million | $45.63 Million | — |